The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSaint Gobain Or Regulatory News (COD)

Share Price Information for Saint Gobain Or (COD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 70.525
Bid: 67.00
Ask: 74.05
Change: -0.25 (-0.35%)
Spread: 7.05 (10.522%)
Open: 70.775
High: 0.00
Low: 0.00
Prev. Close: 70.775
COD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Decisions of Board of Directors

23 Nov 2017 18:12

RNS Number : 4094X
Compagnie de Saint-Gobain
23 November 2017
 

 

 

 

 

 

PRESS RELEASE

 

November 23, 2017

 

Compagnie de Saint-Gobain's Board of Directors decides to propose the renewal of the Director's term of office of Mr. Pierre-André de Chalendar and to co-opt Ms. Dominique Leroy, CEO of Proximus, as an independent Director

 

 

In preparation for the next General Shareholders' Meeting to be held on June 7, 2018, and based on the recommendation of the Nomination and Remuneration Committee, Compagnie de Saint-Gobain's Board of Directors unanimously decided at its meeting today to propose the renewal of the Director's term of office of Mr. Pierre-André de Chalendar for a period of four years.

If the General Shareholders' Meeting approves the renewal of his term of office, the Board of Directors intends to reappoint Mr. Pierre-André de Chalendar as Chairman and Chief Executive Officer of Compagnie de Saint-Gobain.

"I am extremely honoured by the Board of Directors' renewed confidence. If our shareholders approve the decision, I will continue to work with pride and enthusiasm, alongside the entire Saint-Gobain team, in order to pursue the transformation of a Group which plays an increasing role with its customers in contributing positively to their daily lives, and to provide value to our shareholders," said Mr. Pierre-André de Chalendar.

At the proposal of the Nomination and Remuneration Committee, Compagnie de Saint-Gobain's Board of Directors also decided to co-opt Ms. Dominique Leroy as an independent Director to replace Ms. Olivia Qiu, who resigned as Director, for the remainder of her term of office, until the close of the General Shareholder's Meeting to be held to approve the 2018 financial statements. This co-optation, which takes effect today, will be subject to ratification by the General Shareholders' Meeting to be held on June 7, 2018.

Ms. Dominique Leroy is CEO of Proximus, listed on the first market of Euronext Brussels. In addition to this role and her Director's term of office at Saint-Gobain, on January 1st, 2018 she will also serve as an independent member of Ahold Delhaize's Supervisory Board. She will bring to Saint-Gobain's Board of Directors her experience as a non-French executive officer of a listed group, and her operational knowledge of the distribution sector and of digital transformation matters.

 

ABOUT SAINT-GOBAIN

Saint-Gobain designs, manufactures and distributes materials and solutions which are key ingredients in the wellbeing of each of us and the future of all. They can be found everywhere in our living places and our daily life: in buildings, transportation, infrastructure and in many industrial applications. They provide comfort, performance and safety while addressing the challenges of sustainable construction, resource efficiency and climate change.

 

€39.1 billion sales in 2016Operates in 67 countries More than 170,000 employees

www.saint-gobain.com@saintgobain

 

Analyst/Investor relations

Media relations

Vivien Dardel

Florent Nouveau

Floriana Michalowska

 +33 1 47 62 44 29

 +33 1 47 62 30 93

 +33 1 47 62 35 98

Laurence Pernot Susanne Trabitzsch

+33 1 47 62 30 10 +33 1 47 62 43 25

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBJBPTMBBTBMR
Date   Source Headline
25th Apr 20245:16 pmRNS1st Quarter Results
3rd Apr 20245:44 pmRNSAcquisition
26th Mar 20246:01 pmRNSIssue of Debt
15th Mar 20247:16 amRNSVery low carbon siding production in the US
14th Mar 20247:13 amRNSAcquisition
1st Mar 20245:36 pmRNSDisposal
29th Feb 20245:23 pmRNSAnnual Financial Report
26th Feb 20248:12 amRNSAcquisition
21st Feb 20249:07 amRNSSaint-Gobain in advanced talks to acquire CSR
6th Feb 20245:27 pmRNSAgreement
2nd Feb 20247:05 amRNSAcquisition
18th Jan 20245:07 pmRNSAcquisition
15th Jan 20247:22 amRNSAcquisition
15th Dec 20237:05 amRNSAcquisition
12th Dec 20237:11 amRNSAgreement
8th Dec 20235:58 pmRNSRevolving credit facility
7th Dec 20237:09 amRNSAcquisition
6th Dec 20236:05 pmRNSDisposal
23rd Nov 20235:27 pmRNSEvolution of Saint-Gobain’s governance
16th Nov 20236:22 pmRNSIssue of Debt
13th Nov 20239:59 amRNSAcquisition
7th Nov 20237:11 amRNSAgreement
26th Oct 20236:10 pmRNS3rd Quarter Results
10th Oct 20235:13 pmRNSCapital reduction
26th Sep 20234:51 pmRNSAcquisition
20th Sep 20234:57 pmRNSAgreement
1st Sep 20237:04 amRNSDisposal
21st Aug 20237:33 amRNSAcquisition
1st Aug 20237:12 amRNSDisposal
26th Jul 20235:49 pmRNSHalf-year Report
6th Jul 20234:46 pmRNSInvestment
3rd Jul 20237:18 amRNSDisposal
26th Jun 20234:53 pmRNSAcquisition
15th Jun 20237:08 amRNSAcquisition
12th Jun 20235:26 pmRNSAcquisition
9th Jun 20237:00 amRNSGM Statement
8th Jun 20237:03 amRNSDouble-digit operating margin expected for H1 2023
16th May 20234:55 pmRNSPower Purchase Agreement in India
27th Apr 20236:06 pmRNS1st Quarter Results
6th Apr 20235:04 pmRNSNew plant in Norway
30th Mar 20235:09 pmRNSDisposal
30th Mar 20237:13 amRNSFlat glass production using more than 30% hydrogen
16th Mar 20234:54 pmRNSAcquisition
1st Mar 20237:09 amRNSDisposal
23rd Feb 20235:05 pmRNSAnnual Financial Report
22nd Feb 20237:05 amRNSAcquisition
6th Feb 20237:00 amRNSPartnership between Saint-Gobain and AGC
30th Jan 20237:05 amRNSAcquisition
10th Jan 20237:06 amRNSIssue of Debt
4th Jan 20237:10 amRNSAcquisition

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.